Zydus Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zydus Lifesciences has published its audited financial results for Q4 FY2026 and full year ended March 31, 2026. For Q4 FY2026, total income from operations was Rs 75,870 million, up 16% from Rs 65,279 million in Q4 FY2025. Net profit after tax for Q4 stood at Rs 12,725 million, compared to Rs 11,709 million in the same quarter last year. For the full year FY2026, total income was Rs 271,484 million versus Rs 232,415 million in FY2025, representing 17% growth. Full year net profit after tax increased to Rs 42,673 million from Rs 41,257 million. Earnings per share for FY2026 was Rs 50.09 compared to Rs 44.97 in FY2025.
The company delivered steady revenue growth of 17% for the full year with improved profitability metrics, indicating solid operational performance that may be viewed positively by shareholders.